FURTHER OBSERVATIONS ON THE USE OF TRIDIONE IN THE CONTROL OF PSYCHOMOTOR ATTACKS
Abstract
Tridione, a new addition to the treatment of the cerebral dysrhythmias, is helpful in the control of psychomotor seizures. While effective in certain instances if used alone, it is most helpful if used in combination with sodium diphenylhydantoinate and/or phenobarbital.
Toxic symptoms are infrequent in patients who respond to the drug, and do not constitute an important contraindication to its use.
Further research on the oxazolidine-2,-4-dione derivatives and related drugs may afford further advances in the therapy of epilepsy.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
